5 Sources
[1]
Suki Secures USD 70 Million to Expand AI Healthcare Solutions
Suki, an Artificial Intelligence (AI) technology company that provides AI voice solutions for healthcare, has raised USD 70 million in a Series D round, bringing its total funding to USD 165 million. The latest round, led by Hedosophia with substantial additional investment from Venrock and other
[2]
Suki raises $70M for its healthcare-focused AI assistant - SiliconANGLE
Suki AI Inc., a startup with an artificial intelligence assistant for healthcare professionals, has raised $70 million in funding to enhance its technology. London-based fund Hedosophia led the Series D investment. Suki said in its announcement of the deal today that Venrock, March Capital, Flare
[3]
Healthcare startup Suki raises $70 million to build AI assistants for hospitals
(Reuters) - Suki, a startup that offers to build artificial intelligence (AI) assistants in healthcare, has raised $70 million in a Series D round, the company told Reuters, as investors place bets on the adoption of generative AI-powered applications in the sector. The funding round was led by
[4]
Suki Notches $70 Million for AI Healthcare Platform | PYMNTS.com
Healthcare AI firm Suki says it has raised $70 million in new funding. The funding will allow the company to invest in development of its products, which include an artificial intelligence (AI)-powered voice assistant used by clinicians, the company announced in a news release Thursday (Oct.
[5]
Healthcare startup Suki raises $70 million to build AI assistants for hospitals
Oct 10 (Reuters) - Suki, a startup that offers to build artificial intelligence (AI) assistants in healthcare, has raised $70 million in a Series D round, the company told Reuters, as investors place bets on the adoption of generative AI-powered applications in the sector. The funding round was
Share
Copy Link
Suki, an AI technology company specializing in voice solutions for healthcare, has raised $70 million in a Series D funding round. The investment will be used to accelerate product development, expand commercial initiatives, and grow its leadership team.

Suki, an artificial intelligence (AI) technology company specializing in voice solutions for healthcare, has successfully secured $70 million in a Series D funding round
1
2
3
. This latest investment brings the company's total funding to $165 million, highlighting the growing interest in AI-powered healthcare solutions.The funding round was led by London-based tech investment firm Hedosophia, with significant additional investments from existing backers including Venrock, March Capital, Flare Capital, Breyer Capital, and inHealth Ventures
1
2
. While Suki did not disclose its valuation, a source familiar with the funding round reported that the company is now valued at approximately $500 million3
.Suki offers two primary products: Suki Assistant and Suki Platform. The Suki Assistant is an AI-powered voice assistant designed to streamline administrative tasks for clinicians
1
. It can generate notes ambiently, take dictation and commands, simplify coding, and answer clinical questions by retrieving relevant chart data from electronic health records (EHRs)1
.The Suki Platform, on the other hand, is a suite of developer tools that allows technology partners to build AI experiences into their own solutions
1
2
. Both products have seen increased adoption since the rise of OpenAI's ChatGPT, as healthcare systems explore ways to integrate AI into clinical work3
.Suki boasts broad integration with major EHR systems, including Epic, Oracle Cerner, Athena, and MEDITECH
1
3
. This integration allows for faster documentation and improved workflow efficiency. The company has also expanded its strategic partnership with MedStar Health, making Suki's Assistant available to thousands of MedStar Health clinicians across various specialties1
.Related Stories
According to Suki, its AI assistant can reduce documentation time by up to 72%, leading to a 70% adoption rate across health systems
1
2
. This efficiency gain not only saves time but also improves documentation quality, enhances clinician well-being, and boosts revenue capture1
.With the new funding, Suki plans to accelerate product development, diversify its capabilities, and deepen relationships with strategic partners
1
3
. The company aims to capitalize on the healthcare industry's growing demand for AI solutions, positioning itself as a leader in the field4
.Suki faces competition from established players like Microsoft-owned Nuance, known for its Dragon Medical One software, as well as other AI healthcare startups such as Abridge
3
5
. However, Suki's early entry into the market and its proprietary technology stack give it a competitive edge in the rapidly evolving healthcare AI landscape3
.As the healthcare industry continues to embrace AI technologies, Suki's growth and recent funding success underscore the potential for AI-powered solutions to transform clinical workflows and improve patient care.
Summarized by
Navi
18 Dec 2024•Technology

23 Oct 2024•Technology

22 Sept 2026•Startups

1
Policy and Regulation

2
Technology

3
Policy and Regulation
